Dr. Viviane Zotzmann | Intensive Care Medicine | Best Researcher Award

Dr. Viviane Zotzmann | Intensive Care Medicine | Best Researcher Award

Ortenau Klinikum Offenburg-Kehl, Germany.

PD Dr. med. Viviane Zotzmann is a Senior Consultant for Intensive Care Medicine at Ortenau Klinikum, specializing in internal medicine and cardiology with additional expertise in emergency and intensive care medicine. She has trained in both municipal hospitals and the University Hospital of Freiburg. Dr. Zotzmann is currently responsible for two intensive care units in Offenburg and Lahr. Her research focuses on ECMO therapy, with particular interest in survival predictors, quality of life, and functional outcomes post-therapy. She is an active member of professional societies such as DGK, DEGUM, DIVI, and DGIM.

Profile

Orcid

🎓 Education

Dr. Viviane Zotzmann holds a Doctor of Medicine (Dr. med.) degree from the University of Tübingen (2005). She is a board-certified specialist in Internal Medicine (2013), Cardiology (2017), and Intensive Care Medicine (2018), with further certification in Cardiovascular Intensive and Emergency Medicine (2022). In addition, she is an Advanced Life Support & Pediatric Life Support Provider (2023). Dr. Zotzmann has also completed additional training in Sonography, Emergency Medicine, and Radiation Protection.

🏥 Professional Experience

Dr. Viviane Zotzmann is a highly experienced medical professional specializing in intensive care, cardiology, and emergency medicine. She currently serves as the Head of Intensive Care Medicine at Ortenau Klinikum (2025 – Present). Previously, she held the position of Senior Consultant at Ortenau Klinikum (2023 – 2025), overseeing Cardiology, Pneumology, Angiology, Geriatrics, Intensive Care, and Thoracic Surgery.

From 2020 to 2023, Dr. Zotzmann was the Lead Physician of Medical Intensive Care Units at University Hospital Freiburg, following her role as a Specialist Physician at the same institution (2016 – 2020). Before that, she served as Senior Physician in Internal Medicine/Cardiology at Zollernalbklinikum (2014 – 2015).

Her medical journey began with specialist training in Internal Medicine & Cardiology at KKH Sigmaringen (2010 – 2014), solidifying her expertise in critical and cardiovascular care.

🔬 Research Interests

Extracorporeal Membrane Oxygenation (ECMO) therapy

Predictors of survival in VV-ECMO and VA-ECMO patients

Quality of life and mental health in post-ECMO patients

Pulmonary embolism diagnosis in ICU patients

Advanced intensive care monitoring and life-support techniques

🏆 Awards & Recognitions

Recognized contributor to ECMO research

Published in high-impact journals such as Intensive Care Medicine and Membranes (Basel)

Cited over 1,044 times with an h-index of 18

📚 Selected Publications

Quality of Life and Mental Health in COVID-ARDS Survivors After V-V ECMO Support: Results from the Freiburg ECMO Outcome Study (FEOS)
Journal of Clinical Medicine, 2025-03-24
DOI: 10.3390/jcm14072206
Contributors: Dawid L. Staudacher, Meret Felder, Markus Jäckel, Felix A. Rottmann, Alexander Supady, Xavier Bemtgen, Philipp Diehl, Tobias Wengenmayer, Viviane Zotzmann

Combining Lung Ultrasound and Wells Score for Diagnosing Pulmonary Embolism in Critically Ill COVID-19 Patients
Journal of Thrombosis and Thrombolysis, 2021-07-03
DOI: 10.1007/s11239-020-02323-0
Contributors: Viviane Zotzmann, Corinna N. Lang, Tobias Wengenmayer, Xavier Bemtgen, Bonaventura Schmid, Katharina Mueller-Peltzer, Alexander Supady, Christoph Bode, Daniel Duerschmied, Dawid L. Staudacher

Combining Lung Ultrasound and Wells Score for Diagnosing Pulmonary Embolism in Critically Ill COVID-19 Patients (Preprint)
2020-09-08
DOI: 10.21203/rs.3.rs-70085/v1
Contributors: Viviane Zotzmann, Corinna Nadine Lang, Tobias Wengenmayer, Xavier Bemtgen, Bonaventura Schmid, Katharina Mueller-Peltzer, Alexander Supady, Christoph Bode, Daniel Duerschmied, Dawid L. Staudacher

Venoarterial Extracorporeal Membrane Oxygenation Decannulation Using the Novel Manta Vascular Closure Device
European Heart Journal: Acute Cardiovascular Care, 2020-05-04
DOI: 10.1177/2048872620918707
Author: V. Zotzmann

Are Subpleural Consolidations Indicators for Segmental Pulmonary Embolism in COVID-19?
Intensive Care Medicine, 2020-04-23
DOI: 10.1007/s00134-020-06044-z
Author: V. Zotzmann

 

 

Dr. James C. L. Chow | Quantum Computing | Best Researcher Award

Dr. James C. L. Chow | Quantum Computing | Best Researcher Award

Princess Margaret Cancer Centre, Canada.

Dr. James Chun Lam Chow, PhD, FCCPM, FInstP, FIET, SMIEEE, PPhys, CPhys, CSci, is a distinguished medical physicist specializing in radiation oncology and artificial intelligence applications in healthcare. He is currently an Associate Professor in Material Science and Engineering at the University of Toronto and a Clinician Investigator at the Princess Margaret Cancer Research Institute. With over two decades of experience in medical physics, his research focuses on AI-driven healthcare solutions, radiation therapy optimization, and Monte Carlo simulations for cancer treatment.

Profile

Google Scholar

Education🎓

Dr. James C. L. Chow earned his PhD in Physics from the University of Hong Kong in 1995 under the supervision of Prof. Peter Fung, following a BSc in Applied Physics (First Class Honours) from City University of Hong Kong in 1992. He was awarded a Croucher Postdoctoral Fellowship at the University of Cambridge (1995-1997), then continued his research as a Postdoctoral Researcher at the University of Toronto (1997-1998) and later as a Postdoctoral Fellow at McMaster University (1998-2000). Transitioning into medical physics, he completed his Medical Physics Residency at the London Regional Cancer Centre (2000-2002), gaining clinical expertise in radiation therapy and medical imaging.

Professional Experience🌟

Dr. James C. L. Chow is an accomplished medical physicist and academic with extensive experience in radiation oncology and materials science. He is currently an Associate Professor in the Department of Materials Science and Engineering at the University of Toronto (2025–Present) and has been an Associate Professor in the Department of Radiation Oncology at the University of Toronto since 2019. In addition to his academic roles, he serves as a Medical Physicist at Princess Margaret Cancer Centre (2005–Present), where he also leads as the Physics On-Call Lead (2010–Present). His research contributions are further reflected in his role as a Clinician Investigator at the Princess Margaret Cancer Research Institute (2023–Present) and his affiliation with the Acceleration Consortium at the University of Toronto (2024–Present).

Previously, Dr. Chow held multiple key positions, including Assistant Professor in Radiation Oncology at the University of Toronto (2006–2019) and Medical Physics Site Lead for Skin Cancer at Princess Margaret Cancer Centre (2010–2015). Before joining Princess Margaret, he worked as a Medical Physicist and Deputy Radiation Safety Officer at Grand River Regional Cancer Centre (2002–2005). He has also contributed to academia as an Adjunct Professor at Ryerson University and the University of Waterloo (2005–2010). His career reflects a deep commitment to advancing medical physics, cancer treatment, and interdisciplinary research in materials science and engineering.

Research Interests📚

Dr. Chow’s research focuses on:

Radiation Oncology & Medical Physics: Treatment optimization using Monte Carlo simulations

Artificial Intelligence in Healthcare: AI-driven diagnostic tools and chatbot applications in oncology

Nanotechnology in Radiation Therapy: Gold nanoparticle-enhanced radiotherapy

Clinical Data Analysis: Predictive modeling for cancer treatment outcomes

Awards & Recognitions🏆

2024 Outstanding Reviewer, Nuclear Engineering and Technology Journal

2024 Most-Viewed Article, JMIR Cancer

2024 Outstanding Author of the Year, AIMS Biophysics Journal

2019 Top Peer Reviewer, Web of Science Group

2012 Outstanding Reviewer, Medical Physics Journal

2010 SciNet Local Resource Allocation Award (1 million supercomputing hours for Monte Carlo simulations)

Selected Publications📖

Gold nanoparticles for drug delivery and cancer therapy
S Siddique, JCL Chow
Applied Sciences 10(11), 3824 (2020) – Cited: 382

Chatbot for health care and oncology applications using artificial intelligence and machine learning: Systematic review
L Xu, L Sanders, K Li, JCL Chow
JMIR Cancer 7(4), e27850 (2021) – Cited: 375

Application of nanomaterials in biomedical imaging and cancer therapy
S Siddique, JCL Chow
Nanomaterials 10(9), 1700 (2020) – Cited: 325

Irradiation of gold nanoparticles by X‐rays: Monte Carlo simulation of dose enhancements and the spatial properties of secondary electron production
MKK Leung, JCL Chow, BD Chithrani, MJG Lee, B Oms, DA Jaffray
Medical Physics 38(2), 624-631 (2011) – Cited: 311

Machine learning in healthcare communication
S Siddique, JCL Chow
Encyclopedia 1(1), 220-239 (2021) – Cited: 142

 

 

Assoc. Prof. Dr. Riccardo Sacco | Mathematical Modeling in Medicine | Best Researcher Award

Assoc. Prof. Dr. Riccardo Sacco | Mathematical Modeling in Medicine | Best Researcher Award

Icahn School of Medicine at Mount Sinai Hospital New York, United States.

Riccardo Sacco is an Italian mathematician and engineer based in New York, USA. He is currently an Associate Scientist at the Icahn School of Medicine, Mount Sinai Hospital, with over two decades of expertise in numerical analysis, computational modeling, and applied mathematics. Riccardo has published extensively, mentoring numerous students and contributing significantly to research in ophthalmology and engineering applications.

Profile

Orcid

🎓 Education

Assoc. Prof. Dr. Riccardo Sacco is a distinguished academic and researcher with expertise in electronic engineering and applied mathematics. Holding a combined B.Sc./M.Sc. in Electronic Engineering from Politecnico di Milano (1989) and a Ph.D. in Applied Mathematics from Università degli Studi di Milano (1993), he has significantly contributed to the field through innovative research and teaching. Following his doctoral studies, Dr. Sacco pursued post-doctoral fellowships at CNR and Università degli Studi di Milano (1993–1995), further advancing his knowledge in applied mathematics. Currently, he serves as an Associate Professor, sharing his expertise and fostering the next generation of engineers and mathematicians.

💼 Experience

Assoc. Prof. Dr. Riccardo Sacco has built a remarkable academic and professional career, blending teaching, research, and global collaboration. Since 2024, he has served as an Associate Scientist at the Icahn School of Medicine, Mount Sinai Hospital in New York, USA, where he contributes to groundbreaking research in applied mathematics and computational methods. Prior to this role, he spent over two decades at Politecnico di Milano (PoliMi), serving as an Associate Professor of Numerical Analysis from 2001 to 2024, and earlier as an Assistant Professor in Numerical Analysis from 1995 to 2001.

Dr. Sacco’s academic journey is enriched by several international appointments as a Visiting Scientist, including at AT&T Bell Labs (1990), Georgia Tech (2003), Université de Strasbourg (2015), and North Carolina State University (2018). These experiences reflect his commitment to advancing numerical analysis and fostering global scientific collaboration.

🔬 Research Interests

Numerical Analysis and Computational Modeling: Application in engineering, medicine, and electronics

Ophthalmology: Modeling aqueous humor dynamics and intraocular pressure

Multi-physics and Multi-scale Problems: Nano-bio-electronics and semiconductor modeling

🏆 Awards and Honors

2010: Co-author of the Most Downloaded Article in Computer Methods in Applied Mechanics and Engineering

2001: Featured in Who’s Who in the World, 18th Edition

📚 Selected Publications

Reduced-Order Model for Cell Volume Homeostasis: Application to Aqueous Humor Production
Mathematical and Computational Applications
2025-01-24 | Journal Article
Contributors: Riccardo Sacco, Greta Chiaravalli, Giovanna Guidoboni, Anita Layton, Gal Antman, Keren Wood Shalem, Alice Verticchio, Brent Siesky, Alon Harris

Reduced-Order Model for Cell Volume Homeostasis: Application to Aqueous Humor Production
Preprint
2024-12-19
Contributors: Riccardo Sacco, Greta Chiaravalli, Giovanna Guidoboni, Anita Layton, Gal Antman, Keren Wood Shalem, Alice Verticchio, Brent Siesky, Alon Harris

The Role of Conventional and Unconventional Adaptive Routes in Lowering Intraocular Pressure: Theoretical Model and Simulation
Physics of Fluids
2023-06-01 | Journal Article
Contributors: Riccardo Sacco, Greta Chiaravalli, Gal Antman, Giovanna Guidoboni, Alice Verticchio, Brent Siesky, Alon Harris

Nanoparticle-Based Retinal Prostheses: The Effect of Shape and Size on Neuronal Coupling
Photonics
2022-09-29 | Journal Article
Contributors: Greta Chiaravalli, Guglielmo Lanzani, Riccardo Sacco

Corrections to “Cardiovascular Function and Ballistocardiogram: A Relationship Interpreted via Mathematical Modeling”
IEEE Transactions on Biomedical Engineering
2020-10 | Journal Article
Contributors: Giovanna Guidoboni, Lorenzo Sala, Moein Enayati, Riccardo Sacco, Marcela Szopos, James M. Keller, Mihail Popescu, Laurel Despins, Virginia H. Huxley, Marjorie Skubic

 

 

 

Dr. Alaa Sayed | Cardiovascular Medicine | Best Researcher Award

Dr. Alaa Sayed | Cardiovascular Medicine | Best Researcher Award

UPMC, United States.

Alaa A. Sayed is a dedicated physician and researcher specializing in internal medicine and regenerative medicine. Currently serving as the Chief Resident in Internal Medicine at UPMC Mercy Hospital in Pittsburgh, Pennsylvania, Alaa's career spans significant roles across clinical practice, research, and global health initiatives. Her work at institutions like the University of Pittsburgh and the World Health Organization reflects her commitment to patient safety and medical innovation.

Profile

Orcid

Google Scholar

Education 🎓

Alaa earned her MBBCh with honors from Beni Suef University, Egypt, demonstrating her early commitment to medical excellence. She further specialized in regenerative medicine by completing a Master’s degree in Novel Therapeutics from Imperial College London. Her research focused on pioneering cardiac stem cell therapies, reflecting her dedication to advancing innovative treatments in cardiovascular health.

Experience 💼

Alaa brings a wealth of experience across various medical and research roles. She served as an Internal Medicine Chief Resident at UPMC Mercy Hospital, where she honed her clinical leadership skills. At the McGowan Institute for Regenerative Medicine, she contributed as a Research Fellow, deepening her expertise in regenerative therapies. Her career also includes a tenure as a Visiting Research Scholar at the University of Missouri and work as a Quality and Patient Safety Consultant with the World Health Organization. Alaa’s dedication to community health is evident in her role as a Primary Care Physician with the Egyptian Ministry of Health.

Research Interests 🔬

Research Specializations: Regenerative Medicine, Patient Safety, and Quality Care
Alaa’s research is deeply rooted in advancing regenerative medicine, particularly focusing on patient safety and quality care. Her work emphasizes the potential of stem cell therapies, striving to bridge the gap between innovative treatments and effective clinical practices.

Technical Expertise: Dry and Wet Lab Techniques
Alaa is highly skilled in both dry and wet lab methodologies, with extensive experience in cultivating and manipulating stem cell cultures. Her technical acumen extends to bioinformatics and AI-driven analysis, where she applies advanced algorithms to enhance diagnostic and therapeutic outcomes.

AI in Healthcare: Deep Learning and Performance Validation
Alaa’s work frequently intersects with thematic analysis and the validation of deep learning models tailored for healthcare. Her research aims to optimize performance metrics of AI applications, ensuring accurate, reliable, and patient-centered results.

Awards 🏆  

Alaa has been recognized for her excellence in patient safety research, and her contributions have been honored by organizations like the WHO and UPMC.

Her awards reflect her impact on improving patient care and advancing medical research.

Publications Top Notes 📚

Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Authors: A. Elgebaly, I. A. I. Radwan, M. M. AboElnas, H. H. Ibrahim, M. F. M. Eltoomy,
Journal: Journal of Gastrointestinal & Liver Diseases, 26(1), 2017. Citations: 89. Link

Functional Microvascularization of Human Myocardium In Vitro
Authors: O. King, D. Cruz-Moreira, A. Sayed, F. Kermani, W. Kit-Anan, I. Sunyovszki,
Journal: Cell Reports Methods, 2(9), 2022. Citations: 24. Link

Implementation Research on Measuring Quality in Primary Care: Balancing National Needs with Learning from the Eastern Mediterranean Region
Authors: M. Letaief, L. R. Hirschhorn, S. Leatherman, A. A. Sayed, A. Sheikh, S. Siddiqi
Journal: International Journal for Quality in Health Care, 33(3), mzab119, 2021. Citations: 7. Link

Vascularized Myocardium-On-A-Chip: Excitation-Contraction Coupling in Perfused Cardiac Co-Cultures
Authors: O. King, D. Cruz-Moreira, S. W. Kit-Anan, A. Sayed, B. Wang, J. Fourre,
Journal: Biophysical Journal, 118(3), 410a, 2020. Citations: 2. Link

Long-Term Association of Low-Density Lipoprotein Subtypes with Coronary Artery Calcium Score and Atherosclerotic Cardiovascular Disease Events: Insights from HeartSCORE Study
Authors: A. Sayed, J. Swanson, K. Kip, E. K. Jesrani, S. Reis, A. Saeed
Journal: Journal of Clinical Lipidology. Link